Clinical Trial

Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China

Name: Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China — clinical trial record (NCT06422117)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of HSK16149 capsule in the treatment of moderate to severe central neuropathic pain compared with placebo.

Trial Details

NCT Number	NCT06422117
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Central Neuropathic Pain
Enrollment	408 participants
Start Date	2024-05-30
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-08-07 (estimated)
Updated on ClinicalTrials.gov	2024-05-20